CSX Stock Analysis: CSX | NASDAQ
Railroads | NASDAQ, USA | Market Cap: 92.777m USD | 12M Return: 53.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 581M
EPS Trend: -69.6%
Qual. Beats: 2
Rev. Trend: -75.5%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CSX Corporation operates a Class I freight railroad providing rail-based transportation services across the United States and Canada. The company runs two business segments-rail and trucking-and serves a diverse set of end markets, including chemicals, agricultural and food products, automotive, forest products, fertilizers, metals, and coal. Its network spans approximately 20,000 route miles across 26 states east of the Mississippi River, the District of Columbia, and the Canadian provinces of Ontario and Quebec, supported by a fleet of roughly 3,400 locomotives and about 30 intermodal terminals.
Beyond line-haul rail services, CSX offers intermodal container and trailer transport, drayage, and rail-to-truck transfer operations that connect non-rail-served customers to its network. The North American Class I rail sector is highly capital-intensive, with high barriers to entry driven by the long-lived nature of track infrastructure, limited rights-of-way, and the large locomotive and rolling stock investments required to operate at scale. CSX is headquartered in Jacksonville, Florida, and was incorporated in 1978.
- Intermodal volume recovery drives revenue as supply chains normalize
- Coal carload declines persist amid energy transition and utility demand softness
- Operating ratio improvement targets margin expansion despite freight cycle headwinds
| Net Income: 3.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 9.06 > 1.0 |
| NWC/Revenue: -5.14% < 20% (prev -4.79%; Δ -0.35% < -1%) |
| CFO/TA 0.12 > 3% & CFO 5.32b > Net Income 3.22b |
| Net Debt (19.3b) to EBITDA (5.64b): 3.42 < 3 |
| Current Ratio: 0.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.86b) vs 12m ago -0.54% < -2% |
| Gross Margin: 35.18% > 18% (prev 34.55%; Δ 0.62% > 0.5%) |
| Asset Turnover: 33.11% > 50% (prev 32.97%; Δ 0.14% > 0%) |
| Interest Coverage Ratio: 4.71 > 6 (EBIT TTM 3.99b / Interest Expense TTM 847.0m) |
| A: -0.02 (Total Current Assets 3.41b - Total Current Liabilities 4.15b) / Total Assets 44.7b |
| B: 0.25 (Retained Earnings 11.4b / Total Assets 44.7b) |
| C: 0.09 (EBIT TTM 3.99b / Avg Total Assets 43.8b) |
| D: 0.46 (Book Value of Equity 14.1b / Total Liabilities 30.6b) |
| Altman-Z'' = 1.81 = BBB |
| DSRI: 1.01 (Receivables 1.46b/1.41b, Revenue 14.5b/14.2b) |
| GMI: 0.98 (GM 34.55% / 35.18%) |
| AQI: 10.05 (AQ_t 0.91 / AQ_t-1 0.09) |
| SGI: 1.03 (Revenue 14.5b / 14.2b) |
| TATA: -0.05 (NI 3.22b - CFO 5.32b) / TA 44.7b) |
| Beneish M = 2.34 (Cap -4..+1) = D |
As of July 24, 2026, the stock is trading at USD 52.81 with a total of 29,142,399 shares traded. Over the past week, the price has changed by +3.77%, over one month by +14.41%, over three months by +14.71% and over the past year by +53.15%.
Current recommended Stop Loss: 51.50 (which is 2.5% or 1.4 ATR below the current price).
CSX has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CSX.
- StrongBuy: 11
- Buy: 5
- Hold: 11
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 50.6 | -4.1% |
P/E Trailing = 30.6319
P/E Forward = 26.1097
P/S = 6.551
P/B = 6.859
P/EG = 2.2499
Revenue TTM = 14.5b USD
EBIT TTM = 3.99b USD
EBITDA TTM = 5.64b USD
Long Term Debt = 18.2b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.70b USD (from shortTermDebt, last quarter)
Debt = 20.3b USD (corrected: LT Debt 18.2b + ST Debt 1.70b) + Leases 469.0m
Net Debt = 19.3b USD (calculated: Debt 20.3b - CCE 1.01b)
Enterprise Value = 112b USD (92.8b + Debt 20.3b - CCE 1.01b)
Interest Coverage Ratio = 4.71 (Ebit TTM 3.99b / Interest Expense TTM 847.0m)
EV/FCF = 18.26x (Enterprise Value 112b / FCF TTM 6.14b)
FCF Yield = 5.48% (FCF TTM 6.14b / Enterprise Value 112b)
FCF Margin = 42.31% (FCF TTM 6.14b / Revenue TTM 14.5b)
Net Margin = 22.21% (Net Income TTM 3.22b / Revenue TTM 14.5b)
Gross Margin = 35.18% ((Revenue TTM 14.5b - Cost of Revenue TTM 9.41b) / Revenue TTM)
Gross Margin QoQ = none% (prev 47.90%)
Tobins Q-Ratio = 2.51 (Enterprise Value 112b / Total Assets 44.7b)
Interest Expense / Debt = 4.17% (Interest Expense 847.0m / Debt 20.3b)
Taxrate = 8.14% (342.0m / 4.20b)
NOPAT = 3.67b (EBIT 3.99b * (1 - 8.14%))
Current Ratio = 0.82 (Total Current Assets 3.41b / Total Current Liabilities 4.15b)
Debt / Equity = 1.44 (Debt 20.3b / totalStockholderEquity, last quarter 14.1b)
Debt / EBITDA = 3.42 (Net Debt 19.3b / EBITDA 5.64b)
Debt / FCF = 3.15 (Net Debt 19.3b / FCF TTM 6.14b)
Total Stockholder Equity = 13.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.35% (Net Income 3.22b / Total Assets 44.7b)
RoE = 24.06% (Net Income TTM 3.22b / Total Stockholder Equity 13.4b)
RoCE = 12.64% (EBIT 3.99b / Capital Employed (Equity 13.4b + L.T.Debt 18.2b))
RoIC = 8.82% (NOPAT 3.67b / Invested Capital 41.5b)
WACC = 7.49% (E(92.8b)/V(113b) * Re(8.29%) + D(20.3b)/V(113b) * Rd(4.17%) * (1-Tc(0.08)))
Discount Rate = 8.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.08 | Cagr: -2.37%
[DCF] Terminal Value 77.97% ; FCFF base≈4.49b ; Y1≈5.14b ; Y5≈7.57b
[DCF] Fair Price = 50.90 (EV 114b - Net Debt 19.3b = Equity 94.6b / Shares 1.86b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -69.60 | EPS CAGR: -4.08% | SUE: 1.64 | # QB: 2
Revenue Correlation: -75.47 | Revenue CAGR: -1.43% | SUE: 1.47 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.52 | Chg30d=+1.96% | Revisions=+57% | Analysts=19
EPS current Year (2026-12-31): EPS=1.95 | Chg30d=+2.10% | Revisions=+62% | GrowthEPS=+21.2% | GrowthRev=+6.6%
EPS next Year (2027-12-31): EPS=2.22 | Chg30d=+2.48% | Revisions=+67% | GrowthEPS=+13.9% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +83% (up=15, down=0)